A detailed history of State Of Wyoming transactions in Dexcom Inc stock. As of the latest transaction made, State Of Wyoming holds 50 shares of DXCM stock, worth $4,002. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Previous 766 93.47%
Holding current value
$4,002
Previous $86,000 96.51%
% of portfolio
0.0%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$64.0 - $116.06 $45,824 - $83,098
-716 Reduced 93.47%
50 $3,000
Q2 2024

Aug 14, 2024

BUY
$110.31 - $140.45 $80,636 - $102,668
731 Added 2088.57%
766 $86,000
Q1 2024

May 13, 2024

BUY
$114.22 - $140.1 $228 - $280
2 Added 6.06%
35 $4,000
Q4 2023

Feb 14, 2024

BUY
$75.49 - $124.16 $226 - $372
3 Added 10.0%
33 $4,000
Q3 2023

Nov 14, 2023

BUY
$86.06 - $137.93 $1,376 - $2,206
16 Added 114.29%
30 $2,000
Q2 2023

Aug 14, 2023

SELL
$112.47 - $130.98 $130,577 - $152,067
-1,161 Reduced 98.81%
14 $1,000
Q1 2023

May 12, 2023

BUY
$104.0 - $122.92 $120,640 - $142,587
1,160 Added 7733.33%
1,175 $136,000
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $254 - $368
3 Added 25.0%
15 $1,000
Q2 2022

Aug 15, 2022

SELL
$67.99 - $132.89 $15,977 - $31,229
-235 Reduced 95.14%
12 $1,000
Q1 2022

May 13, 2022

SELL
$94.08 - $130.2 $3,010 - $4,166
-32 Reduced 11.47%
247 $126,000
Q4 2021

Feb 11, 2022

SELL
$129.87 - $162.82 $11,688 - $14,653
-90 Reduced 24.39%
279 $150,000
Q3 2021

Feb 11, 2022

SELL
$106.71 - $143.18 $20,595 - $27,633
-193 Reduced 34.34%
369 $202,000
Q2 2021

Feb 11, 2022

BUY
$80.99 - $107.93 $17,736 - $23,636
219 Added 63.85%
562 $240,000
Q1 2021

Feb 08, 2022

BUY
$84.79 - $104.74 $29,082 - $35,925
343 New
343 $123,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.